Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,919 | 147 | 89.8% |
| Education | $444.92 | 6 | 10.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Almirall LLC | $554.54 | 8 | $0 (2021) |
| ABBVIE INC. | $548.81 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $536.11 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $285.07 | 8 | $0 (2024) |
| LEO Pharma Inc. | $248.31 | 13 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $244.71 | 6 | $0 (2024) |
| GENZYME CORPORATION | $244.50 | 9 | $0 (2023) |
| Galderma Laboratories, L.P. | $211.11 | 9 | $0 (2021) |
| PFIZER INC. | $193.86 | 6 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $158.82 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $515.58 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($120.43) |
| 2023 | $397.54 | 13 | Sun Pharmaceutical Industries Inc. ($89.95) |
| 2022 | $660.53 | 25 | E.R. Squibb & Sons, L.L.C. ($132.35) |
| 2021 | $365.68 | 15 | VYNE Pharmaceuticals Inc. ($53.00) |
| 2020 | $189.70 | 6 | Janssen Biotech, Inc. ($157.31) |
| 2019 | $489.25 | 20 | Almirall LLC ($165.73) |
| 2018 | $1,188 | 34 | Almirall LLC ($366.22) |
| 2017 | $557.48 | 22 | Janssen Biotech, Inc. ($138.80) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 06/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: IMMUNOLOGY | ||||||
| 05/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: DERMATOLOGY | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.72 | General |
| 04/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Dermatology | ||||||
| 04/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.82 | General |
| Category: Immunology | ||||||
| 04/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.80 | General |
| Category: Immunology | ||||||
| 04/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $34.28 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Immunology | ||||||
| 03/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: DERMATOLOGY | ||||||
| 01/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: IMMUNOLOGY | ||||||
| 01/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $34.01 | General |
| Category: Immunology | ||||||
| 11/15/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $35.49 | General |
| Category: Immunology | ||||||
| 10/24/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2023 | Sun Pharmaceutical Industries Inc. | — | Education | In-kind items and services | $72.00 | General |
| 10/17/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.46 | General |
| Category: Dermatology | ||||||
| 10/16/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $59.99 | General |
| Category: Immunology | ||||||
| 10/10/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 467 | 599 | $86,091 | $46,482 |
| 2022 | 7 | 431 | 553 | $79,280 | $43,029 |
| 2021 | 6 | 401 | 517 | $74,733 | $42,703 |
| 2020 | 7 | 352 | 462 | $59,045 | $31,291 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 187 | 290 | $34,872 | $20,466 | 58.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 73 | 92 | $16,045 | $9,021 | 56.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 95 | 95 | $13,259 | $7,689 | 58.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 51 | $9,690 | $4,993 | 51.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,640 | $2,307 | 49.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 18 | 22 | $3,850 | $934.40 | 24.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 11 | 11 | $2,475 | $927.64 | 37.5% |
| 87101 | Fungal culture (mold or yeast) of skin, hair, or nail | Office | 2023 | 15 | 19 | $1,260 | $143.63 | 11.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 153 | 248 | $30,095 | $17,875 | 59.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 83 | 102 | $17,925 | $9,985 | 55.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 105 | 105 | $14,680 | $9,206 | 62.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 41 | $7,775 | $3,768 | 48.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,000 | $1,220 | 40.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 21 | 27 | $4,725 | $838.97 | 17.8% |
| 87101 | Fungal culture (mold or yeast) of skin, hair, or nail | Office | 2022 | 16 | 18 | $1,080 | $137.12 | 12.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 167 | 256 | $30,732 | $19,025 | 61.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 88 | 88 | $12,360 | $8,002 | 64.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 68 | 84 | $14,575 | $7,938 | 54.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 44 | $8,360 | $4,945 | 59.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 24 | 33 | $5,776 | $1,452 | 25.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,930 | $1,341 | 45.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 140 | 221 | $24,300 | $12,944 | 53.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 57 | 73 | $11,560 | $7,033 | 60.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 75 | 75 | $9,375 | $5,941 | 63.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 31 | $5,425 | $2,111 | 38.9% |
About Dr. Eleanor Ford, MD
Dr. Eleanor Ford, MD is a Dermatology healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396768560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eleanor Ford, MD has received a total of $4,364 in payments from pharmaceutical and medical device companies, with $515.58 received in 2024. These payments were reported across 153 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,919).
As a Medicare-enrolled provider, Ford has provided services to 1,651 Medicare beneficiaries, totaling 2,131 services with total Medicare billing of $163,506. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Silver Spring, MD
- Active Since 07/26/2006
- Last Updated 10/27/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396768560
Products in Payments
- TREMFYA (Drug) $347.92
- Humira (Biological) $266.06
- DUPIXENT (Biological) $264.59
- Sotyktu (Drug) $244.71
- STELARA (Biological) $244.32
- EUCRISA (Drug) $193.86
- Seysara (Drug) $168.08
- RINVOQ (Biological) $135.92
- ADBRY (Biological) $135.75
- DUPIXENT DUPILUMAB INJECTION (Biological) $129.91
- SKYRIZI (Biological) $127.58
- Ceracade (Drug) $127.22
- SPEVIGO (Drug) $120.43
- DUPIXENT (Drug) $117.18
- EPIDUO FORTE (Drug) $114.11
- ENSTILAR (Drug) $112.56
- SOOLANTRA (Drug) $80.57
- Tremfya (Drug) $68.79
- COSENTYX (Biological) $67.55
- DORYX (Drug) $67.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Silver Spring
Dr. Benjamin Lockshin, Md, MD
Dermatology — Payments: $4.1M
Dr. Amy Cole, Md, MD
Dermatology — Payments: $15,910
Dr. Norman Lockshin, Md, MD
Dermatology — Payments: $3,753
Kavita Goyal, M.d, M.D
Dermatology — Payments: $1,414
Michelle Levender, Md, MD
Dermatology — Payments: $1,410
Edward Cowen, M.d, M.D
Dermatology — Payments: $762.26